A Türkiye Sigorta policy’s most truthful scene is often not a gleaming technology showcase, but a bank branch. The company describes itself as an institution moving the insurance experience from “after” to “before,” aiming to be recognized within ten years as a global technology company. Yet the Q1 ledger shows an older and stronger machine: 4,942 bank branches, thousands of agents, the desks of public banks, and a long book filled with motor claims.
This is not a dismissal. Türkiye Sigorta’s investment case begins exactly here. In the first quarter of 2026, gross premiums rose to 53.8 billion TL, net profit reached 6.45 billion TL, and the combined ratio fell from 99% to 90%. In insurance, that means the factory is running with less waste. But on the back page of the same ledger sit 46.50 billion TL of net outstanding claims before discount, a 20.61 billion TL discount on top of that, and 19.39 billion TL of other financial debt used in investment activities.
The Premium Written by the Branch
The company was born in 2020 from the merger of Ziraat Sigorta, Halk Sigorta, and Güneş Sigorta under one roof. The main shareholder is TVF Finansal Yatırımlar with an 81.10% stake. This ownership structure does not merely sit on the capital table; the distribution muscle of the income statement also runs through it.
In Q1, premiums written through related-party channels Ziraat Bank, Halkbank, and Vakıfbank reached 25.97 billion TL. Total gross premium in the same period was 53.81 billion TL. In other words, roughly half of the story flows through Turkey’s public-bank artery. That does not have to be a bad thing. On the contrary, in insurance, the party that controls distribution cost and customer access can make money for a long time. But it says the stock should be valued not as a “technology platform,” but as bancassurance strength plus pricing discipline.
| Item | 2026Q1 | Read-through |
|---|---|---|
| Total gross written premium | TRY 53.81bn | 30% year-on-year growth. |
| Premium written through related banks | TRY 25.97bn | About 48% of total gross written premium. |
| Commissions paid to related banks | TRY 2.56bn | The visible cost of distribution strength. |
| Free float | 18.90% | Control sits with TVF Finansal Yatırımlar A.Ş. |
The branch mix is not simple either. In premium production, general damages rose to 21.13 billion TL, or 39.3% of the total; fire and natural disasters reached 12.37 billion TL; health was 5.65 billion TL. While health premiums declined year on year, health claims took 4.23 billion TL, or 29% of paid claims. Motor third-party liability is still loss-making in technical balance: minus 816 million TL in Q1. That is why the insurance company’s landscape is not simply “leadership”; it is a table where good lines carry bad lines, and where reinsurance and reserves never leave the conversation.
The Interest Inside the Profit
Q1 technical segment balance was 6.89 billion TL. That is a good number, but not a naked one. The financial notes say income earned from investing the assets covering non-life technical provisions is transferred to the technical segment. In Q1, investment income transferred from the non-technical segment to the technical segment was 4.90 billion TL.
This is not a trick; it is insurance accounting. Still, it reminds the investor of this: Türkiye Sigorta’s profit does not come only from pricing policies correctly. The company collects premiums, sets aside provisions, carries the assets behind those provisions, and then interest and investment income become part of the technical result. So “90% combined ratio” is not enough on its own; one must also ask in what interest-rate and reserve environment that ratio was produced.
The company’s investment book is large: financial assets of 92.47 billion TL and cash and cash equivalents of 13.59 billion TL. Together they make 106.06 billion TL, or 1.94 times the 54.75 billion TL in equity. Managed well, that scale enlarges return on equity. Managed poorly, or if rates, FX, or liquidity turn against it, the same leverage comes down on capital.
In Q1, net investment income, when investment income and expenses are read together, was 1.34 billion TL. Income from financial investments rose to 7.89 billion TL, but valuation of financial investments produced a 448 million TL loss; investment management expenses including interest climbed to 1.07 billion TL. This is not deposit complacency. It is active balance-sheet management.
The Heavy Page of the Claims Ledger
At Türkiye Sigorta, the largest risk is not that capital disappears; it is that capital thins out through claims estimation. At the end of Q1, the net outstanding claims provision before discount stood at 46.50 billion TL. Of this, 20.61 billion TL is deducted through the discount effect, leaving 25.89 billion TL of discounted net outstanding claims on the balance sheet.
The heaviest line is motor third-party liability. In this branch, net outstanding claims before discount are 36.78 billion TL; after discount, 18.44 billion TL. In long-tail motor liability claims, courts, wages, inflation, and discount assumptions sit at the same table. Even a small change in assumptions at this table can enlarge the ledger.
The company also discloses that the possible liability that could arise if lawsuits related to insured claims are concluded against it, including interest and expenses, is 12.48 billion TL, and states that this has been considered within the net outstanding claims provision. This is not a new bomb; it is inside the reserve book. But this is exactly what tests the cheapness claim in the stock: if reserves are sufficient, the profit is high quality; if reserves are lagging, today’s P/E is cheap only on paper.
| Item | Amount | Why it matters |
|---|---|---|
| Pre-discount net outstanding claims reserve | TRY 46.50bn | The economic size of the claims ledger. |
| Outstanding claims reserve discount | TRY 20.61bn | A balance-sheet relief item tied to assumptions. |
| Discounted net outstanding claims reserve | TRY 25.89bn | The net reserve carried on the balance sheet. |
| Motor liability discounted outstanding claims | TRY 18.44bn | The main long-tail motor risk line. |
| Potential liability from claim lawsuits | TRY 12.48bn | Included in the net outstanding claims reserve. |
The recourse and salvage side is not a clean footnote either. The company shows 903.8 million TL of net recourse receivables under receivables from main operations; 3.27 billion TL of net recourse receivables pursued through litigation and enforcement are classified under doubtful receivables, with provisions set aside against them. The accounting appears properly built, but it tells the reader this: this company’s ledger is made not only of policies sold, but of collection, litigation, enforcement, and reserve discipline.
Valuation: Expensive Book or Cheap Earnings?
Using market data from 18 May 2026, the share price is 13.70 TL and the market capitalization is 137.0 billion TL. Since Q1 equity was 54.75 billion TL, P/B is 2.50x. For an insurance company, this is not a “free book.” Yet the same company posted 6.45 billion TL in net profit in Q1. Annualized, that profit becomes 25.81 billion TL and P/E falls to 5.31x. On a more conservative TTM calculation, when 2026Q1 is added to 2025 annual profit and 2025Q1 is removed, net profit is roughly 21.44 billion TL; P/E is 6.39x.
This is where the cheapness is born. The market is paying 2.5 times book value, but that book, at the Q1 run rate, is producing roughly 47% annualized return on equity. If sustainable ROE falls to 30%, 2.5x book becomes expensive. If ROE remains in the 35-40% band, a 6-7x earnings multiple looks too stingy.
| Approach | Calculation | Read-through |
|---|---|---|
| P/B | TRY 137.0bn market value / TRY 54.75bn equity = 2.50x | Book is not cheap; high ROE is required. |
| TTM P/E | TRY 137.0bn / TRY 21.44bn TTM net profit = 6.39x | The market heavily discounts earnings durability. |
| Annualized Q1 P/E | TRY 137.0bn / TRY 25.81bn annualized Q1 profit = 5.31x | If Q1 pace holds, the stock remains cheap. |
| Annualized Q1 ROE | TRY 6.45bn x 4 / TRY 54.75bn = 47% | The core number defending 2.50x book. |
| Reserve sensitivity | 25% of the TRY 20.61bn outstanding-claims discount equals TRY 5.15bn | Sensitivity only; about 9.4% of equity. |
My bridge is this: the market is not fully pricing Türkiye Sigorta’s Q1 quality; but it is applying a justified claims-ledger discount. That is why the decision is not a bare “cheap P/E” decision. The decision is whether the 90% combined ratio is temporary. If the company stays in the 90-95% band, the bancassurance channel preserves high volume, and investment borrowings are carried without eating profit, the 137 billion TL market value remains too low. If the combined ratio moves back above 100%, today’s cheapness disappears quickly.
Management Language and the Real Test
Management language loves the future: technology, preventive insurance, trust, global scale. The Q1 numbers show a rougher success. Public banks bring policies; the company spreads catastrophic risk through a large reinsurance network; financial assets and technical provisions feed profit; the motor liability ledger still stands at capital’s throat.
This is not a bad contradiction. It only needs to be named correctly. Türkiye Sigorta’s investment thesis is not “the fintech of insurance.” The thesis is that a large and repeatable distribution channel, when combined with correct pricing and adequate reserves, can produce high return on equity.
The anti-thesis is also strong. 2.50x book value is not a level to take lightly in a market like Turkey, where inflation and interest-rate volatility are high. Financials without TMS 29 inflation adjustment may make nominal growth look brighter. The 19.39 billion TL portion of other financial debt is short term and used in investment activities. Volume coming through related public banks is an advantage; it is also a question about independent distribution quality.
Verdict
My verdict on Türkiye Sigorta: Cheap.
This is not riskless cheapness. There is a reasonable path to finding the stock expensive: if the reserve discount is too optimistic, if motor liability claims reopen, if the economics of bancassurance commissions deteriorate, or if the combined ratio turns back above 100%, 2.5x book becomes a hard multiple.
But the Q1 ledger in hand says something else. 53.8 billion TL in premiums, a 90% combined ratio, 6.45 billion TL in net profit, 6.39x TTM P/E, and nearly 47% annualized ROE; these are not numbers to be pushed aside with a simple sentence that “there is risk.” The market is correctly applying a discount to the claims ledger, but that discount is punishing the current strength of the profit machine too heavily.
This stock is not for everyone. It is not for the investor who wants a clean balance sheet and does not want to read motor liability reserves or the public-bank channel. But for the investor who knows that in insurance, profit is earned not before the claim arrives, but when the claim has been sufficiently priced, Türkiye Sigorta is a stake in the claims ledger behind the policy sold at the bank branch.